Ramesh Kumar is no longer serving in their board position at Onconova Therapeutics, Inc.
Jan 16, 2019
Board and Executive Moves
Former Director at DNX Biotherapeutics
In The News
Ocugen Announces Completion of its Merger with Histogenics to CreateNasdaq-Listed Clinical-Stage Company Developing Novel Ocular Gene Therapies and Biotherapeutics
Sep 30, 2019 - Business Wire
Mar 26, 2019 - Marketline Newswire
Jan 15, 2019 - GlobeNewswire
Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the identification and development of oncology therapeutics. It focuses on discovering and developing small molecule drug candidates to treat cancer. The company was founded by Ramesh Kumar and E. Premkumar Reddy on December 22, 1998 and is headquartered in Newtown, PA.
In The News
-Onconova Therapeutics Announces that the Required Number of Survival Events Has Been Reached for the Pivotal Phase 3 INSPIRE Trial Data Analysis
Jul 30, 2020 - ENP Newswire
-Onconova Therapeutics Submits Application for Rigosertib to Participate in Federally Funded Human Studies in COVID-19 Disease
Jul 28, 2020 - ENP Newswire